Exosome therapy delivers small vesicles released by cells rather than the cells themselves. These vesicles carry proteins and genetic material and are studied for their role in communication between cells. Because nothing living is administered, the preparation is handled and stored differently from a cell-based treatment, and the schedule is usually shorter.
That difference removes the collection step, which is one reason the approach appeals to patients traveling for treatment. It also raises separate questions. Ask where the source material comes from, how it is screened, and how the preparation is characterized before use. Clinics differ considerably in how much detail they provide on these points.
Evidence in this area is still developing, and results reported so far vary by application. Ask what is known about the specific use proposed to you rather than about exosomes in general. Ask what would be measured afterward and over what period. Regulatory treatment of these products also differs by country, which affects what may be offered privately and is worth understanding before consultation.
